RECRUITING

Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)

Description

Early diabetic kidney disease (DKD) occurs in 50-70% of youth with type 2 diabetes (T2D) and confers high lifetime risk of dialysis and premature death. Youth-onset T2D typically manifests during or shortly after puberty in adolescents with obesity. Epidemiological data implicate puberty as an accelerator of kidney disease in youth with obesity and diabetes and the investigators posit that the link between puberty and T2D-onset may explain the high burden of DKD in youth-onset T2D. A better understanding of the impact of puberty on kidney health is needed to promote preservation of native kidney function, especially in youth with T2D.

Study Overview

Study Details

Study overview

Early diabetic kidney disease (DKD) occurs in 50-70% of youth with type 2 diabetes (T2D) and confers high lifetime risk of dialysis and premature death. Youth-onset T2D typically manifests during or shortly after puberty in adolescents with obesity. Epidemiological data implicate puberty as an accelerator of kidney disease in youth with obesity and diabetes and the investigators posit that the link between puberty and T2D-onset may explain the high burden of DKD in youth-onset T2D. A better understanding of the impact of puberty on kidney health is needed to promote preservation of native kidney function, especially in youth with T2D.

PANTHER Study: Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress

Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)

Condition
Type 2 Diabetes Mellitus
Intervention / Treatment

-

Contacts and Locations

Aurora

Children's Hospital Colorado, Aurora, Colorado, United States, 80045

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * HbA1c ≥6.0% for untreated high-risk group
  • * BMI ≥ 95th %ile for high-risk group
  • * Normal HbA1c ≤5.6% for control group
  • * Type 1 diabetes (T1D) Antibody negative
  • * History of Chronic kidney disease (CKD) or acute kidney injury (AKI)
  • * Metabolic disorder prohibiting safe fasting
  • * Iodine or penicillin allergy
  • * Pregnancy
  • * Thrombophilia
  • * MRI contraindications
  • * Hormone therapy

Ages Eligible for Study

8 Years to 14 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Colorado, Denver,

Petter Bjornstad, MD, PRINCIPAL_INVESTIGATOR, University of Colorado School of Medicine

Study Record Dates

2027-12-01